← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-5 · 마지막 9월 2일

현재 선택: 1개 · 임상 갱신 필요 1개

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

API CSV14행 · 1개 프로그램
OverviewToxicologyClinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
AntibodyLimited DatastalePhase 2
CC-1 and Toczilizumab (CC-1 and Toczilizumab)
German Cancer Research Center·Lung Cancer Squamous Cell
1 trials
Overview
Program
CC-1 and Toczilizumab
Overview
Company
German Cancer Research Center
Overview
Modality
ANTIBODY
Overview
Target
Lung Cancer Squamous Cell
Overview
Indication
Lung Cancer Squamous Cell
Overview
Phase
PHASE_2
Overview
Status
DISCONTINUED
Overview
Content status
Limited Data
Overview
Data Confidence
Data Confidence · Low
Overview
Development Signal
Development Signal · Emerging
Overview
Approval status
Investigational
Toxicology
Major finding
WGS analysis and virulence of Streptococcus suis serotype 4 ST1689 isolated from an asymptomatic pig, Thailand.. Streptococcus suis causes severe disease in pigs and is implicated increasingly in human infections, posing a substantial zoonotic threat to global public health, with many human and pig infections being caused by S. suis serotype 2, especially strains belonging to clonal complex (CC) 1…
Clinical
Safety signal
WGS analysis and virulence of Streptococcus suis serotype 4 ST1689 isolated from an asymptomatic pig, Thailand.. Streptococcus suis causes severe disease in pigs and is implicated increasingly in human infections, posing a substantial zoonotic threat to global public health, with many human and pig infections being caused by S. suis serotype 2, especially strains belonging to clonal complex (CC) 1…
Clinical
Program phase
PHASE_2